Dr. Sinha-Hikim is an experienced researcher and has worked in various medical schools in the United States since 1985. During these years, he has advanced from a Rockefeller Foundation post-doctoral fellow at Harvard Medical School, through the professorial ranks, to a full Professor at David Geffen School of Medicine at UCLA. In 2010, he joined as a Professor, at Department of Internal Medicine, Charles R. Drew University of Medicine and science. He also has a dual appointment as a Professor-in-Residence, Department of Medicine, David Geffen School of Medicine at UCLA. Dr. Sinha-Hikim has contributed to research in translational and biomedical sciences and to the mentoring of high school, undergraduate and graduate students, PHD or MD Fellows, and junior faculty.

Scholarly Activities

Dr. Sinha-Hikim has published 133 peer-reviewed articles, 1 book, and 14 book chapters in his fields. Most recently, he published an editorial and co-edited an e-book on obesity, smoking, and fatty liver disease consisting of 10 articles (9 reviews and 1 original) for Frontiers in Endocrinology that provides a comprehensive assessment of the impact of nicotine and obesity on various diseases, including NAFLD. His works appeared in premiere journals of his discipline, including Apoptosis, Biology of Reproduction, Endocrinology, Genes & Development, Hepatology, Journal of Clinical Investigation, Journal of Gerontology: Biological Sciences, and Molecular Endocrinology.

Research Interests

Current research in his laboratory focuses on cardio-metabolic diseases targeted to define the contribution of nicotine (either parenterally administered or delivered via electronic nicotine delivery systems) and obesity to the development of cardiomyopathy, skeletal muscle abnormalities, and nonalcoholic fatty liver disease (NAFLD).